Study Name: Study To Evaluate The Efficacy And Safety Of PH-797804 For 12 Weeks In Adults With Moderate To Severe Chronic Obstructive Pulmonary Disease (COPD) On
14 locations found
- Pfizer Investigational Site
Location: Waterbury, Connecticut 06708
- Pfizer Investigational Site
Location: Rochester, New York 14618
- Pfizer Investigational Site
Location: Pawtucket, Rhode Island 02860
- Pfizer Investigational Site
Location: Warwick, Rhode Island 02886
- Pfizer Investigational Site
Location: Montclair, California 91763
- Pfizer Investigational Site
Location: San Diego, California 92120
- Pfizer Investigational Site
Location: Fort Mitchell, Kentucky 41017
- Pfizer Investigational Site
Location: St. Louis, Missouri 63141
- Pfizer Investigational Site
Location: Cincinnati, Ohio 45231
- Pfizer Investigational Site
Location: Cincinnati, Ohio 45245
- Pfizer Investigational Site
Location: Cincinnati, Ohio 45242
- Pfizer Investigational Site
Location: Oklahoma City, Oklahoma 73112
- Pfizer Investigational Site
Location: San Antonio, Texas 78212
- Pfizer Investigational Site
Location: Midvale, Utah 84047
|